29 Mar 2017 | 3:39 PM
 

Dr. Lal Pathlabs Ltd. Share Price Live (BSE)
0

BSE Code: 539524 | NSE Symbol: LALPATHLAB
937.05
-5.45
(-0.57 %)
29 Mar 2017 | 03:24 PM
Change company
  • Open (Rs)
    946.00
  • Prev. close (Rs.)
    942.50
  • High (Rs.)
    949.00
  • Low (Rs.)
    937.00
  • 52W H (Rs.)
    1,278.55
  • 52W L (Rs.)
    792.50
  • Volume (Rs.)
    16590
  • MCap (Rs in Cr.)
    7,757.00
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
15.99
Operating Margin (%)
26.50
Gross Profit Margin (%)
22.92
Net Profit Margin (%)
16.70
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
18.59
Earning Retention Ratio
81.56

News

02 Mar 2017 - 12:42:00-Westbridge Crossover sold 1...
02 Mar 2017 - 12:32:00-Westbridge Crossover has sold 1...
02 Feb 2017 - 15:00:00-Dr...
29 Jul 2016 - 16:27:00-Healthcare firm Dr Lal PathLabs Ltd on Friday registered a surge of 29...

Announcements

27-Mar-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi
17-Mar-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi
15-Mar-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi
08-Mar-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi
06-Mar-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi

Religare Research

29 Mar 2017 | 12:21 PM
Agri Fundamental and Technical report
29 Mar 2017 | 09:47 AM
The Indian rupee rose to a 17-month high against the dollar, as U.S. President Donald Trump's failur...
29 Mar 2017 | 09:22 AM
• Gold steadied as investors weighed Trump agenda prospects • US natural gas regained strength amid...
29 Mar 2017 | 07:00 AM
We expect volatility to increase in the next two sessions due to scheduled derivatives expiry.Trader...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors58.61%
Mutual Funds/UTI4.37%
FI/Banks1.44%
Insurance1.44%
FII7.12%
Government0.00%
Others23.83%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
4,565.50(-0.97)
3280
 Pfizer Ltd.
1,800.45(-0.36)
3370
 Wockhardt Ltd.
724.00(-1.09)
3787
 Thyrocare Technologies Ltd.
709.00(2.26)
17383

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Dr. Lal Pathlabs Ltd.-38.40-107.20-196.15
NIFTY(S&P CNX)264.201,108.95398.65
BSE SENSEX800.213,332.851,250.72
BSE 500373.701,720.92664.27

Corporate Details

Key Personal
Arvind Lal
Chairman & Managing Director
Naveen Wadhera
Non Exe. & Nominee Director
Om Prakash Manchanda
WholeTime Director & CEO
Key Address
Registered Office
Block E Sector 18 Rohini,New Delhi,Delhi

Tel:011-30244199, Fax:011-27882134

cs@lalpathlabs.com
https://www.lalpathlabs.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Dr. Lal Pathlabs Ltd. that will help you decide whether to buy, sell or hold Dr. Lal Pathlabs Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Dr. Lal Pathlabs Ltd.